The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
Home
Podcast: Generic Biologics
A Senate committee has approved legislation to create an FDA regulatory pathway for generic biologics. Mary Agnes Carey, associate editor of CQ HealthBeat, comments on this recent activity.
July 5, 2007
Sign up for our eNewsletters
Get the latest news and updates
Sign Up
Related
Charles River reports lower Q4 2025 revenue in struggling CDMO business
UK pharmaceuticals exempt from tariffs in US drug pricing agreement
Sponsored
2026 Manufacturing Pharma Trends for Life Sciences
Sponsored
2026 AI Trends in Life Sciences
Trending
Charles River inks agreement to divest CDMO, cell solutions businesses to GI Partners
A mix of old and new, Basel emerges as a leading European biopharma hub
Eli Lilly feels strain of its $50B US capital expansion since 2020
Sponsored Picks
Sponsored
2026 Manufacturing Pharma Trends for Life Sciences
Sponsored
2026 AI Trends in Life Sciences
Sponsored
2026 Manufacturing Medical Device Trends for Life Sciences
Load More Content